monoclonal antibody
[免疫] 单克隆抗体
2025-06-27 14:28 浏览次数 5
[免疫] 单克隆抗体
hybridom techniques have made mouse monoclonal antibody widely use in diagnosis and research of human disease, and established the first milestone of therapeutic antibody.
杂交瘤技术使鼠源单克隆抗体(鼠单抗)被广泛用于人类疾病的诊断和研究,建立了治疗性抗体的第一个里程碑。
to preparate the monoclonal antibody against the human heparanase for further research of clinical diagnosis of the tumour.
制备抗人肝素酶单克隆抗体,用于肝素酶的研究及临床恶性肿瘤的鑒别诊断。
monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to the carboxy terminus of the human histone h3 protein.
该单克隆抗体是采用合成的与人组蛋白h3蛋白羧基基端肽段免疫动物而生产的。
monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human fip200 protein.
该单克隆抗体是采用合成的人fip200蛋白羧基末端附近的残基相对应的肽段免疫动物制备。
the specificity of the assay can be improved by using monoclonal antibody as enzyme-linked antibody.
用单克隆抗体作为酶结合物抗体可以提高实验方法的特异性。
set up a stable and effective method of isolation and purification early pregnancy factor for getting enough epf as antigen preparing for gaining the monoclonal antibody of epf.
建立一条稳定高效的分离纯化epf的技术路线,以获得充足高纯度的epf作为抗原,为进一步制备抗-epf单克隆抗体作準备。
method (1)virus seed testing: to confirm the neutralization capacity of monoclonal antibody by neutralization test with monoclonal antibody and hav vaccine virus seed.
方法(1)毒种检定:将单克隆抗体与甲肝病毒进行中和试验,观察单克隆抗体的中和作用;
monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to the amino terminus of the sequence of human egr1.
该单克隆抗体由合成的人类egr1蛋白氨基末端附近肽段免疫动物而制成。
they developed avastin, a breakthrough monoclonal antibody that already earns $4 billion a year as a cancer fighter, and is on track to become the world’s most lucrative drug by 2014.
该公司研发了阿瓦斯丁,一个带有突破意义的单克隆癌癥抗体;此举每年可为公司创造40亿美元,而且必将在2014年成为全球活力能力最强的药品。
monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to the sequence of human pdhk1 protein.
单克隆抗体通过用对应于人源pdhk1蛋白序列的合成肽免疫动物制备而得。
patients who need treatment may receive chemotherapy or monoclonal antibody therapy alone or in combination.
需要治疗的患者可单独或合并使用化和单克隆抗体疗法。
monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding cysteine 57 of human traf1.
该单克隆抗体是采用合成的人源traf1蛋白半胱氨酸57周围残基相对应的肽段免疫动物而制备的。
bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor, is approved by the us food and drug administration for metastatic colon cancer.
由美国食品与药品管理局批準治疗转移克隆癌的贝伐单抗,是血管内皮生长因子的单克隆抗体。
compared with conventional therapy, monoclonal antibody based on targeted therapy has unparalleled advantage and it has seen a great clinical application potential.
与常规治疗相比,以单克隆抗体为主的靶向治疗有着无可比拟的优势,临床应用前景良好。
one monoclonal antibody is in development for potential use in the regeneration of corticospinal tract fibers resulting from an acute spinal injury.
一种在研的单克隆抗体作为潜在的用于急性脊髓损伤的皮质脊髓束纤维再生的药物。
monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to the sequence of the human suz12 protein.
通过合成的与人源suz12蛋白相应的多肽片段去免疫动物从而制备出此单克隆抗体。
monoclonal antibody is produced by immunizing animals with a fusion protein containing the cytoplasmic domain of human egf receptor.
该单克隆抗体是通过用包含人egf受体胞质域的融合蛋白免疫动物而制备的。
objective: to identify a functional monoclonal antibody 1e2 against lung cancer and its antigen, so as to provide a candidate antibody drug and molecule target for the anti-lung cancer therapy.
目的:鑒定抑制肺癌细胞生长的功能性单克隆抗体1e2及其抗原,为治疗肺癌提供有潜力的靶向抗体治疗剂和分子靶位。
monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human gapdh protein.
该单克隆抗体用与人类gapdh蛋白中羧基末端附近的氨基酸序列对应的人工合成肽段免疫动物制成。
there are two directors here who live here in princeton, and one of them is of class 83 - christian schade who is the chief financial officer of medarex a monoclonal antibody company here in town.
我们有两位董事就居住在普林斯顿,其中一位christian,schade是83届校友,他是medarex公司的首席财务官,该公司位于这的一家单克隆抗体公司。
monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to the sequence of human ldha.
单克隆抗体通过用对应于人源ldha蛋白序列的合成肽免疫动物制备而得。
since 1975 when the technology of hybridoma and monoclonal antibody was developed, many investigators have been paying close attention to antibody targeting therapy for patients with cancer.
自从1975年发现了单克隆抗体技术和不久后提出生物导弹设想以来,导向治疗受到许多科研工作者的关注。
objective:to prepare the monoclonal antibody of ppo and study the expression in malignant melanoma.
目的:制作ppo的单克隆抗体并研究其在恶性黑色素瘤中的表达。
monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the carboxy terminus of human fgf receptor 1 protein.
该单克隆抗体是通过用重组蛋白免疫动物而制备的,该重组蛋白是人fgf受体1蛋白的羧基末端。
the treatments may include drug therapy, monoclonal antibody therapy, stem cell transplantation , and radiation therapy for some patients.
这些治疗包括药物治疗、单克隆抗体治疗、干细胞移植,以及针对某些患者的放射治疗。
study on the monoclonal antibody to chlorpyrifos.
抗毒死蜱单克隆抗体的研制。